Evidence map›Paper›PMID 34191626›Full record

ReviewAmerican journal of physiology. Cell physiology2021

Mitochondrial transplantation in cardiomyocytes: foundation, methods, and outcomes.

Paria Ali Pour, Sina Hosseinian, Arash Kheradvar

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Cell physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Triaptosis and Cancer: Next Hope?Research (Washington, D.C.) · 2025
    Review
  17. Review
  18. Review
  19. Review
  20. Controlled Release of Hydrogen-Carrying Perfluorocarbons for Ischemia Myocardium-TargetingAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Paria Ali PourEdwards Lifesciences Center for Advanced Cardiovascular Technology, Irvine, California.ORCID 0000-0002-0463-3927
Sina HosseinianEdwards Lifesciences Center for Advanced Cardiovascular Technology, Irvine, California.ORCID 0000-0003-4100-9178
Arash KheradvarEdwards Lifesciences Center for Advanced Cardiovascular Technology, Irvine, California.ORCID 0000-0003-3864-1359
University of California, Irvine · US

Funding

Training Program in Cardiovascular Applied Research and EntrepreneurshipT32HL116270 · NHLBI · UNIVERSITY OF CALIFORNIA-IRVINE · PI HUGHES, CHRISTOPHER C. W. · 2013 to 2022
$1.6M
NHLBI NIH HHS T32 HL116270
6 · The paper itself

Abstract

Mitochondrial transplantation is emerging as a novel cellular biotherapy to alleviate mitochondrial damage and dysfunction. Mitochondria play a crucial role in establishing cellular homeostasis and providing cell with the energy necessary to accomplish its function. Owing to its endosymbiotic origin, mitochondria share many features with their bacterial ancestors. Unlike the nuclear DNA, which is packaged into nucleosomes and protected from adverse environmental effects, mitochondrial DNA are more prone to harsh environmental effects, in particular that of the reactive oxygen species. Mitochondrial damage and dysfunction are implicated in many diseases ranging from metabolic diseases to cardiovascular and neurodegenerative diseases, among others. While it was once thought that transplantation of mitochondria would not be possible due to their semiautonomous nature and reliance on the nucleus, recent advances have shown that it is possible to transplant viable functional intact mitochondria from autologous, allogenic, and xenogeneic sources into different cell types. Moreover, current research suggests that the transplantation could positively modulate bioenergetics and improve disease outcome. Mitochondrial transplantation techniques and consequences of transplantation in cardiomyocytes are the theme of this review. We outline the different mitochondrial isolation and transfer techniques. Finally, we detail the consequences of mitochondrial transplantation in the cardiovascular system, more specifically in the context of cardiomyopathies and ischemia.

Indexed as

AnimalsCardiomyopathiesCell FractionationDiabetes Mellitus, ExperimentalDisease Models, AnimalHumansInjections, IntralesionalMitochondria, HeartMitochondrial DynamicsMyocardial InfarctionMyocardial Reperfusion InjuryMyocytes, CardiacOxidative PhosphorylationRabbitsRatsReactive Oxygen SpeciesReactive Oxygen Speciesischemia reperfusion injurymitochondrial cardiomyopathymitochondrial diseasesmitochondrial transfermitochondrial transplantation

Identifiers

PMID34191626
PMCPMC8906802
OpenAlexW3175248294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.